Nat New Biol , 1973, 243(124): 85-87
Clinicians should evaluate individual risk factors, comorbidities, and contraindications when choosing patients for treatment, balancing possible benefits with associated dangers
European Journal of Endocrinology / European Federation of Endocrine Societies , 146 (6), 863869.
Table 2 Overview of GLP-1 receptor agonists (GLP-1RAs) approved by the EMA and/or FDA, with year of authorization and main therapeutic indications
How we picked Vitamin C serums, like many skin-care products, have options that can seem both overwhelming and duplicative with price tags that range from about $10 to more than $200
& Foyer, C